Oncology Information System Market
Oncology Information System Market Forecasts to 2028 – Global Analysis By Product & Services Software, Professional Services), Application (Medical Oncology, Radiation Oncology), End User (Government Institutions, Hospitals & Diagnostic Imaging Centers) and By Geography
Years Covered |
2020-2028 |
Estimated Year Value (2021) |
US $7.46 BN |
Projected Year Value (2028) |
US $14.00 BN |
CAGR (2021 - 2028) |
9.4% |
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
Largest Market |
Asia Pacific |
Highest Growing Market |
North America |
According to Stratistics MRC, the Global Oncology Information System Market is accounted for $7.46 billion in 2021 and is expected to reach $14.00 billion by 2028 growing at a CAGR of 9.4% during the forecast period. The Oncology information system (OIS) is defined as comprehensive information & an image management solution that facilitates the management & optimization of the profiles and treatment of cancer patients. This system can achieve patient treatment summaries, treatment schedules, treatment plans, and treatment delivery, and the result is predictable.
Market Dynamics:
Driver:
Rising Government Initiatives
The availability of advanced Healthcare IT solutions for cancer care is generating significant interest among end-users, owing to the better treatment outcomes promised by them. Administrations from all over the world are in the process of planning reforms and introducing new regulations that would help in the enterprise-wide and nationwide adoption of information technologies, including oncology information systems, which aid in the transformation of healthcare systems. For example, in the US, the Health Information Technology for Economic and Clinical Health (HITECH) Act—enacted under the American Recovery and Reinvestment Act (ARRA)—allocated funding for incentivizing hospitals and physicians who demonstrate the meaningful use of EHRs.
Restraint:
High Costs
The systems for various medical devices are extremely expensive. Affordability is a big issue for healthcare businesses, predominantly in emerging economies, where budgetary clearances for IT solutions over medical equipment are often difficult to come by. The high cost associated with the usage of the advanced system is expected to obstruct market growth.
Opportunity:
Branding & Promotion and Initiatives Undertaken by Major Product Manufacturers
Foremost product manufacturers are undertaking strategic initiatives to increase their brand visibility and product awareness among key end-users (such as medical professionals, patients, and oncologists) across major healthcare markets worldwide. Companies functional in this market are choosing for hybrid distribution strategy as per which distribution takes place both by distribution channel and through a partnership with global OIS vendors. The company has also accepted the consignment model, according to which the company places the treatment planning systems along with treatment delivery systems for its customers, and sales are made according to the implementation of medical devices. Such initiatives undertaken by major product manufacturers are expected to increase their brand awareness among target end-users as well as sensitize them about their role in preventive cancer care.
Threat:
Interoperability Issues
Several healthcare organizations have capitalized on a range of oncology information system applications, such as patient information systems, treatment planning systems, treatment management systems and imaging systems, database management systems, and clinical information systems. Integration of these different oncology information systems, however, poses some obstacles—such as data privacy issues. Other issues include a lack of data standardization (which leads to healthcare interoperability) and data inconsistency. The successful integration of oncology information systems with other systems is a focus of IT infrastructure development projects in healthcare organizations offering cancer diagnosis and treatment. This is considered a major threat to the growth of the market during the study period.
Radiation Oncology segment is expected to be the largest during the forecast period
The radiation oncology segment accounted for a larger share of the market. The growing reappearance of the occurrence of secondary cancer cases, the growing number of radiosurgery procedures, and the growing customer base of oncology information systems for radiology are expected to drive the growth of this market.
The hospitals & diagnostic imaging centers segment is expected to have the highest CAGR during the forecast period
The growth of this segment is accredited to a large number of accessibilities to advanced facilities for the diagnosis, treatment, and management of diseases, as well as qualified personnel, which has ensured a constant demand for hospital care and the growth in several hospitals. in the main markets. The influx of cancer patients is considerably higher in hospitals than in other healthcare facilities, which is another key driver for the growth of the market. More radiosurgery procedures are performed in hospitals than in other medical facilities, which contributes to the large share of this end-user segment
Region with highest share:
The Asia Pacific is projected to hold the highest market share, due to the obtainability of advanced healthcare infrastructure and increased knowledge about patient data management in the province. Moreover, the growing use of these systems to track and document cancer patients' treatment outcomes, as well as the role of electronic medical records (EMR) in making better care decisions, are some of the factors that drive the market. Additionally, the rising need to maintain patient schedules, dosage management, and treatment planning in this area is predictable to drive up demand for the market.
Region with highest CAGR:
North America is projected to have the highest CAGR, with the growing population suffering from cancer, along with the burgeoning aging population and progressive developments related to cancer therapy. Rising government initiative for the awareness of cancer in the country is also a propelling factor for growth in this province. These factors are anticipated to further drive the market in this province.
Key players in the market:
Some of the key players profiled in the Oncology Information System Market include Accuray Incorporated, BMSI Partners Inc, BrainLab, Cerner Corporation, CureMD Corporation, DOSIsoft S.A., Elekta AB, F Hoffmann-LA Roche Ag , Flatiron, Koninklijke Philips NV, McKesson Corporation, MIM Software, Nasdaq Inc , Philips Healthcare, Prowess, Inc., RaySearch Laboratories, Siemens AG , Varian Medical Systems, ViewRay Inc.
Key developments:
In December 2020: Koninklijke Philips N.V. (Netherlands) launched the advanced Philips IntelliSite Pathology Solution to leverage precision diagnosis for oncology
In September 2020: Siemens Healthineers set foot into a definitive agreement to acquire Varian Medical Systems. This acquisition will bolster the company’s currently existing product mix of oncology information systems.
In September 2020: Varian Medical Systems, Inc. (US) announced that it had granted FDA approval for the Eclipse v16.1 treatment planning software for cancer therapy.
Product & Services Covered:
• Software
• Professional Services
Applications Covered:
• Medical Oncology
• Radiation Oncology
• Surgical Oncology
End Users Covered:
• Ablation Care Centers and Cancer Care Centers
• Government Institutions
• Hospitals & Diagnostic Imaging Centers
• Research Facilities
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2020, 2021, 2022, 2025 and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Oncology Information System Market, By Product & Services
5.1 Introduction
5.2 Software
5.2.1 Patient Information Systems
5.2.1.1 Chemotherapy Information System
5.2.1.2 Laboratory Information Systems
5.2.1.3 Oncology Electronic Medical Record (EHR)
5.2.1.4 Radiology Information systems
5.2.2 Treatment Planning Systems
5.2.2.1 Brachytherapy Treatment Planning Systems
5.2.2.2 Clinical Decision Support Systems
5.2.2.3 Radiotherapy Treatment Planning Systems
5.2.3 Treatment Management Systems & Medical Image Analysis Systems
5.2.3.1 Advanced Visulaization & Image Analysis Solutions
5.2.3.2 Clinical Integration Solutions
5.2.3.3 Picture archiving and communication System (PACS) & VNA
5.2.3.4 Population Health Management
5.2.3.5 Radiation Dose Management Solutions
5.3 Professional Services
5.3.1 Consulting/Optimization Services
5.3.2 Implementation Services
5.3.3 Post-Sale and Maintenance Services
6 Global Oncology Information System Market, By Application
6.1 Introduction
6.2 Medical Oncology
6.3 Radiation Oncology
6.4 Surgical Oncology
7 Global Oncology Information System Market, By End User
7.1 Introduction
7.2 Ablation Care Centers and Cancer Care Centers
7.3 Government Institutions
7.4 Hospitals & Diagnostic Imaging Centers
7.5 Research Facilities
8 Global Oncology Information System Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 Italy
8.3.4 France
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 New Zealand
8.4.6 South Korea
8.4.7 Rest of Asia Pacific
8.5 South America
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 UAE
8.6.3 Qatar
8.6.4 South Africa
8.6.5 Rest of Middle East & Africa
9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 Company Profiling
10.1 Accuray Incorporated
10.2 BMSI Partners Inc
10.3 BrainLab
10.4 Cerner Corporation
10.5 CureMD Corporation
10.6 DOSIsoft S.A.
10.7 Elekta AB
10.8 F Hoffmann-LA Roche Ag
10.9 Flatiron
10.10 Koninklijke Philips NV
10.11 McKesson Corporation
10.12 MIM Software
10.13 Nasdaq Inc
10.14 Philips Healthcare
10.15 Prowess, Inc.
10.16 RaySearch Laboratories
10.17 Siemens AG
10.18 Varian Medical Systems
10.19 ViewRay Inc.
List of Tables
1 Global Oncology Information System Market Outlook, By Region (2020-2028) (US $MN)
2 Global Oncology Information System Market Outlook, By Product & Services (2020-2028) (US $MN)
3 Global Oncology Information System Market Outlook, By Software (2020-2028) (US $MN)
4 Global Oncology Information System Market Outlook, By Patient Information Systems (2020-2028) (US $MN)
5 Global Oncology Information System Market Outlook, By Treatment Planning Systems (2020-2028) (US $MN)
6 Global Oncology Information System Market Outlook, By Treatment Management Systems & Medical Image Analysis Systems (2020-2028) (US $MN)
7 Global Oncology Information System Market Outlook, By Professional Services (2020-2028) (US $MN)
8 Global Oncology Information System Market Outlook, By Consulting/Optimization Services (2020-2028) (US $MN)
9 Global Oncology Information System Market Outlook, By Implementation Services (2020-2028) (US $MN)
10 Global Oncology Information System Market Outlook, By Post-Sale and Maintenance Services (2020-2028) (US $MN)
11 Global Oncology Information System Market Outlook, By Application (2020-2028) (US $MN)
12 Global Oncology Information System Market Outlook, By Medical Oncology (2020-2028) (US $MN)
13 Global Oncology Information System Market Outlook, By Radiation Oncology (2020-2028) (US $MN)
14 Global Oncology Information System Market Outlook, By Surgical Oncology (2020-2028) (US $MN)
15 Global Oncology Information System Market Outlook, By End User (2020-2028) (US $MN)
16 Global Oncology Information System Market Outlook, By Ablation Care Centers and Cancer Care Centers (2020-2028) (US $MN)
17 Global Oncology Information System Market Outlook, By Government Institutions (2020-2028) (US $MN)
18 Global Oncology Information System Market Outlook, By Hospitals & Diagnostic Imaging Centers (2020-2028) (US $MN)
19 Global Oncology Information System Market Outlook, By Research Facilities (2020-2028) (US $MN)
20 North America Oncology Information System Market Outlook, By Country (2020-2028) (US $MN)
21 North America Oncology Information System Market Outlook, By Product & Services (2020-2028) (US $MN)
22 North America Oncology Information System Market Outlook, By Software (2020-2028) (US $MN)
23 North America Oncology Information System Market Outlook, By Patient Information Systems (2020-2028) (US $MN)
24 North America Oncology Information System Market Outlook, By Treatment Planning Systems (2020-2028) (US $MN)
25 North America Oncology Information System Market Outlook, By Treatment Management Systems & Medical Image Analysis Systems (2020-2028) (US $MN)
26 North America Oncology Information System Market Outlook, By Professional Services (2020-2028) (US $MN)
27 North America Oncology Information System Market Outlook, By Consulting/Optimization Services (2020-2028) (US $MN)
28 North America Oncology Information System Market Outlook, By Implementation Services (2020-2028) (US $MN)
29 North America Oncology Information System Market Outlook, By Post-Sale and Maintenance Services (2020-2028) (US $MN)
30 North America Oncology Information System Market Outlook, By Application (2020-2028) (US $MN)
31 North America Oncology Information System Market Outlook, By Medical Oncology (2020-2028) (US $MN)
32 North America Oncology Information System Market Outlook, By Radiation Oncology (2020-2028) (US $MN)
33 North America Oncology Information System Market Outlook, By Surgical Oncology (2020-2028) (US $MN)
34 North America Oncology Information System Market Outlook, By End User (2020-2028) (US $MN)
35 North America Oncology Information System Market Outlook, By Ablation Care Centers and Cancer Care Centers (2020-2028) (US $MN)
36 North America Oncology Information System Market Outlook, By Government Institutions (2020-2028) (US $MN)
37 North America Oncology Information System Market Outlook, By Hospitals & Diagnostic Imaging Centers (2020-2028) (US $MN)
38 North America Oncology Information System Market Outlook, By Research Facilities (2020-2028) (US $MN)
39 Europe Oncology Information System Market Outlook, By Country (2020-2028) (US $MN)
40 Europe Oncology Information System Market Outlook, By Product & Services (2020-2028) (US $MN)
41 Europe Oncology Information System Market Outlook, By Software (2020-2028) (US $MN)
42 Europe Oncology Information System Market Outlook, By Patient Information Systems (2020-2028) (US $MN)
43 Europe Oncology Information System Market Outlook, By Treatment Planning Systems (2020-2028) (US $MN)
44 Europe Oncology Information System Market Outlook, By Treatment Management Systems & Medical Image Analysis Systems (2020-2028) (US $MN)
45 Europe Oncology Information System Market Outlook, By Professional Services (2020-2028) (US $MN)
46 Europe Oncology Information System Market Outlook, By Consulting/Optimization Services (2020-2028) (US $MN)
47 Europe Oncology Information System Market Outlook, By Implementation Services (2020-2028) (US $MN)
48 Europe Oncology Information System Market Outlook, By Post-Sale and Maintenance Services (2020-2028) (US $MN)
49 Europe Oncology Information System Market Outlook, By Application (2020-2028) (US $MN)
50 Europe Oncology Information System Market Outlook, By Medical Oncology (2020-2028) (US $MN)
51 Europe Oncology Information System Market Outlook, By Radiation Oncology (2020-2028) (US $MN)
52 Europe Oncology Information System Market Outlook, By Surgical Oncology (2020-2028) (US $MN)
53 Europe Oncology Information System Market Outlook, By End User (2020-2028) (US $MN)
54 Europe Oncology Information System Market Outlook, By Ablation Care Centers and Cancer Care Centers (2020-2028) (US $MN)
55 Europe Oncology Information System Market Outlook, By Government Institutions (2020-2028) (US $MN)
56 Europe Oncology Information System Market Outlook, By Hospitals & Diagnostic Imaging Centers (2020-2028) (US $MN)
57 Europe Oncology Information System Market Outlook, By Research Facilities (2020-2028) (US $MN)
58 Asia Pacific Oncology Information System Market Outlook, By Country (2020-2028) (US $MN)
59 Asia Pacific Oncology Information System Market Outlook, By Product & Services (2020-2028) (US $MN)
60 Asia Pacific Oncology Information System Market Outlook, By Software (2020-2028) (US $MN)
61 Asia Pacific Oncology Information System Market Outlook, By Patient Information Systems (2020-2028) (US $MN)
62 Asia Pacific Oncology Information System Market Outlook, By Treatment Planning Systems (2020-2028) (US $MN)
63 Asia Pacific Oncology Information System Market Outlook, By Treatment Management Systems & Medical Image Analysis Systems (2020-2028) (US $MN)
64 Asia Pacific Oncology Information System Market Outlook, By Professional Services (2020-2028) (US $MN)
65 Asia Pacific Oncology Information System Market Outlook, By Consulting/Optimization Services (2020-2028) (US $MN)
66 Asia Pacific Oncology Information System Market Outlook, By Implementation Services (2020-2028) (US $MN)
67 Asia Pacific Oncology Information System Market Outlook, By Post-Sale and Maintenance Services (2020-2028) (US $MN)
68 Asia Pacific Oncology Information System Market Outlook, By Application (2020-2028) (US $MN)
69 Asia Pacific Oncology Information System Market Outlook, By Medical Oncology (2020-2028) (US $MN)
70 Asia Pacific Oncology Information System Market Outlook, By Radiation Oncology (2020-2028) (US $MN)
71 Asia Pacific Oncology Information System Market Outlook, By Surgical Oncology (2020-2028) (US $MN)
72 Asia Pacific Oncology Information System Market Outlook, By End User (2020-2028) (US $MN)
73 Asia Pacific Oncology Information System Market Outlook, By Ablation Care Centers and Cancer Care Centers (2020-2028) (US $MN)
74 Asia Pacific Oncology Information System Market Outlook, By Government Institutions (2020-2028) (US $MN)
75 Asia Pacific Oncology Information System Market Outlook, By Hospitals & Diagnostic Imaging Centers (2020-2028) (US $MN)
76 Asia Pacific Oncology Information System Market Outlook, By Research Facilities (2020-2028) (US $MN)
77 South America Oncology Information System Market Outlook, By Country (2020-2028) (US $MN)
78 South America Oncology Information System Market Outlook, By Product & Services (2020-2028) (US $MN)
79 South America Oncology Information System Market Outlook, By Software (2020-2028) (US $MN)
80 South America Oncology Information System Market Outlook, By Patient Information Systems (2020-2028) (US $MN)
81 South America Oncology Information System Market Outlook, By Treatment Planning Systems (2020-2028) (US $MN)
82 South America Oncology Information System Market Outlook, By Treatment Management Systems & Medical Image Analysis Systems (2020-2028) (US $MN)
83 South America Oncology Information System Market Outlook, By Professional Services (2020-2028) (US $MN)
84 South America Oncology Information System Market Outlook, By Consulting/Optimization Services (2020-2028) (US $MN)
85 South America Oncology Information System Market Outlook, By Implementation Services (2020-2028) (US $MN)
86 South America Oncology Information System Market Outlook, By Post-Sale and Maintenance Services (2020-2028) (US $MN)
87 South America Oncology Information System Market Outlook, By Application (2020-2028) (US $MN)
88 South America Oncology Information System Market Outlook, By Medical Oncology (2020-2028) (US $MN)
89 South America Oncology Information System Market Outlook, By Radiation Oncology (2020-2028) (US $MN)
90 South America Oncology Information System Market Outlook, By Surgical Oncology (2020-2028) (US $MN)
91 South America Oncology Information System Market Outlook, By End User (2020-2028) (US $MN)
92 South America Oncology Information System Market Outlook, By Ablation Care Centers and Cancer Care Centers (2020-2028) (US $MN)
93 South America Oncology Information System Market Outlook, By Government Institutions (2020-2028) (US $MN)
94 South America Oncology Information System Market Outlook, By Hospitals & Diagnostic Imaging Centers (2020-2028) (US $MN)
95 South America Oncology Information System Market Outlook, By Research Facilities (2020-2028) (US $MN)
96 Middle East & Africa Oncology Information System Market Outlook, By Country (2020-2028) (US $MN)
97 Middle East & Africa Oncology Information System Market Outlook, By Product & Services (2020-2028) (US $MN)
98 Middle East & Africa Oncology Information System Market Outlook, By Software (2020-2028) (US $MN)
99 Middle East & Africa Oncology Information System Market Outlook, By Patient Information Systems (2020-2028) (US $MN)
100 Middle East & Africa Oncology Information System Market Outlook, By Treatment Planning Systems (2020-2028) (US $MN)
101 Middle East & Africa Oncology Information System Market Outlook, By Treatment Management Systems & Medical Image Analysis Systems (2020-2028) (US $MN)
102 Middle East & Africa Oncology Information System Market Outlook, By Professional Services (2020-2028) (US $MN)
103 Middle East & Africa Oncology Information System Market Outlook, By Consulting/Optimization Services (2020-2028) (US $MN)
104 Middle East & Africa Oncology Information System Market Outlook, By Implementation Services (2020-2028) (US $MN)
105 Middle East & Africa Oncology Information System Market Outlook, By Post-Sale and Maintenance Services (2020-2028) (US $MN)
106 Middle East & Africa Oncology Information System Market Outlook, By Application (2020-2028) (US $MN)
107 Middle East & Africa Oncology Information System Market Outlook, By Medical Oncology (2020-2028) (US $MN)
108 Middle East & Africa Oncology Information System Market Outlook, By Radiation Oncology (2020-2028) (US $MN)
109 Middle East & Africa Oncology Information System Market Outlook, By Surgical Oncology (2020-2028) (US $MN)
110 Middle East & Africa Oncology Information System Market Outlook, By End User (2020-2028) (US $MN)
111 Middle East & Africa Oncology Information System Market Outlook, By Ablation Care Centers and Cancer Care Centers (2020-2028) (US $MN)
112 Middle East & Africa Oncology Information System Market Outlook, By Government Institutions (2020-2028) (US $MN)
113 Middle East & Africa Oncology Information System Market Outlook, By Hospitals & Diagnostic Imaging Centers (2020-2028) (US $MN)
114 Middle East & Africa Oncology Information System Market Outlook, By Research Facilities (2020-2028) (US $MN)
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.